"Presbyterian Heart and Vascular Care is a nationally recognized team of specialists who focus on the diagnosis, management and treatment of diseases that affect the heart and circulatory system. This includes cardiology, interventional cardiology, cardiothoracic surgery, vascular surgery, and pediatric/ congenital cardiology. Our Heart and Vascular Care team provides a wide range of advanced diagnostic and treatment services. These include diagnostic testing and imaging, medication therapy, surgical and interventional procedures, ongoing monitoring, and cardiac rehabilitation."

During the past decade, Presbyterian Heart Group conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presbyterian Heart Group" #1 sponsor was "Medtronic" with 5 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "Yale University" with 2 trials sponsored and "Baim Institute for Clinical Research" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Heart Group" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Heart Group" are "Heart Failure" (8 trials), "Acute Myocardial Infarction" (2 trials), "Ventricular Tachycardia" (2 trials), "Cardiovascular Disease" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Presbyterian Heart Group" in a lesser frequency.

Most popular intervention types in "Presbyterian Heart Group" are "Device" (10 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BAROSTIM NEO® System" (1 trials), "BiV/MPP" (1 trials), "CRT-D System" (1 trials), "Cardiac Resynchronization Therapy - MPP" (1 trials) and "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Heart Group" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Presbyterian Heart Group". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Presbyterian Heart Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Heart Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".